Randomized phase Ⅲ study of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic adenocarcinoma of the pancreas(MPACT). In2013 ASCO Gastrointestinal Cancers Symposium,abstract,2012,24-26 .Best supportive care(BSC)ver ......